Michael R Hayden, Director at AbCellera Biologics, bought ABCL on Aug 24, 2026

Data as of Oct 16

▲ BUY$570K53,613 shares at $10.64Michael R Hayden DirectorABCL AbCellera Biologics Inc.

Watch ABCL

Traded: Aug 24, 2026
Disclosed: Aug 24, 2026
Filed: The same day

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

ABCLSimilar stocks (XLV — its sector index fund), rebased to ABCL's price on the disclosure day

ABCL since disclosure

+11.2%

Similar stocks (XLV) since disclosure

+1.2%

XLV — its sector index fund

Change in closing price from Aug 24, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

See every trade on ABCL →